Session Information
Date: Monday, October 22, 2018
Title: Systemic Lupus Erythematosus – Etiology and Pathogenesis Poster II
Session Type: ACR Poster Session B
Session Time: 9:00AM-11:00AM
Background/Purpose:
Cutaneous lupus erythematosus (CLE) and dermatomyositis (DM) are autoimmune diseases. The histopathological pattern of skin involvement can be similar, i.e. interface dermatitis, but the systemic manifestations are very different. While dermatomyositis commonly affect muscles, lupus erythematosus may affect any organ system. Autoantibodies against intracellular targets are common in both conditions, but the specific targets of the autoantibodies differ between the two conditions.
Our aim was to investigate a whole proteome of inflammatory foci of the CLE and DM lesions in a comparator manner and identify disease unique mechanisms of inflammation.
Methods: Patients with CLE (n=6), DM (n=5) and controls (n=6) were included and biopsied at diagnosis or disease exacerbation. Skin biopsies were examined by a pathologist, and selected inflammatory foci were laser microdissected. The total protein content of the microdissected tissue was then analyzed using mass-spectrometry.
Results:
In DM, there were 25 highly upregulated proteins, while CLE infiltrates were more protein rich and there were 88 proteins with up to 9-fold upregulation. Protein expression comparison between CLE and DM identified 22 differentially upregulated proteins, and all had higher abundance in CLE than in DM. A protein network analysis was performed by STRING platform (string-db.org). The network of interferon (IFN)-regulated proteins was abundant in both CLE and DM, including: IFIT, MX, OAS, STAT gene families and also EIF2AK2. Also, proteins involved in oxidative stress and antigen processing: IL4I1, TAP1 and TAP2 were highly upregulated in both CLE and DM. Proteins expressed differentially in CLE covered complement proteins (C1b), including membrane attack complex (C5, C6, C7, C8A and B) and complement regulators (CFHR1, CFHR2, CFHR5). Also, regulators of coagulation: thrombospondin 2 (THBS2), thrombin (F2) and annexin A3 (ANXA3) were highly abundant in CLE.
Conclusion: Inflammatory foci in the interface dermatitis in CLE and DM contain high abundance of IFN-regulated proteins, as well as regulators of oxidative stress and antigen processing. The proteomics technique allowed identification of pathways differentially activated in CLE, including complement activation products and regulators of coagulation. Our study identified multiple pathways activated at the site of inflammation which will be of interest in further search of new therapeutic targets.
To cite this abstract in AMA style:
Niewold TB, Meves A, Lehman JS, Popovic-Silwerfeldt K, Charlesworth C, Wahren-Herlenius M, Svenungsson E, Oke V. Comparative Analysis of the Total Proteome of the Skin Lesions from Cutaneous Lupus Erythematosus (CLE) and Dermatomyositis (DM) [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/comparative-analysis-of-the-total-proteome-of-the-skin-lesions-from-cutaneous-lupus-erythematosus-cle-and-dermatomyositis-dm/. Accessed .« Back to 2018 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/comparative-analysis-of-the-total-proteome-of-the-skin-lesions-from-cutaneous-lupus-erythematosus-cle-and-dermatomyositis-dm/